Study of immuno-Cell therapy for advanced and recurrent gastrointestinal and Hepato-biliary-pancreatic carcinoma
Not Applicable
Recruiting
- Conditions
- Advanced and recurrent gastrointestinal and hepato-biliary-pancreatic carcinoma
- Registration Number
- JPRN-UMIN000013187
- Lead Sponsor
- Toho University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.patient who was malignant lymphoma, or leukemia 2.HTLV-1 antibody, or HIV antibody is positive 3.patient who has interstitial pneumonia 4.patient who has activated autoimmune 5.patient who has activated cardiac disease 6.patient who has severe drug allergy 7.pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method